Fetal Valproate Syndrome

National Organization for Rare Disorders, Inc.

Important
It is possible that the main title of the report Fetal Valproate Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Synonyms

  • Dalpro, Fetal Effects From
  • Depakene, Fetal Effects From
  • Depakote Sprinkle, Fetal Effects From
  • Depakote, Fetal Effects From
  • Divalproex, Fetal Effects From
  • Epival, Fetal Effects From
  • Myproic Acid, Fetal Effects From
  • Valproic Acid, Fetal Effects From
  • Fetal Anti-Convulsive Syndrome

Disorder Subdivisions

  • None

General Discussion

Fetal Valproate Syndrome is a rare congenital disorder caused by exposure of the fetus to valproic acid (dalpro, depakene, depakote, depakote sprinkle, divalproex, epival, myproic acid) during the first three months of pregnancy. Valproic acid is an anticonvulsant drug used to control certain types of seizures in the treatment of epilepsy. A small percentage of pregnant women who take this medication can have a child with Fetal Valproate Syndrome. The exact prevalence of this condition remains to be established. Symptoms of this disorder may include spina bifida, distinctive facial features, and other musculoskeletal abnormalities.

Resources

Spina Bifida Association of America
4590 MacArthur Boulevard NW
Suite 250
Washington, DC 20007-4226
Tel: (202)944-3285
Fax: (202)944-3295
Tel: (800)621-3141
Email: sbaa@sbaa.org
Internet: http://www.sbaa.org

International Federation for Spina Bifida and Hydrocephalus
Cellebroersstraat 16
Brussels, B1000
Belgium
Tel: +32 (0)2 502 0413
Fax: +32 (0)2 502 1129
Email: info@ifglobal.org
Internet: http://www.ifglobal.org

Spina Bifida and Hydrocephalus Association of Canada
Suite 428-167
av. Lombard Avenue
Winnipeg,, R3B 0V3
Canada
Tel: 204-925-3650
Fax: 204-925-3654
Tel: 800-565-9488
Email: spinab@mts.net
Internet: http://www.sbhac.ca

National Fetal AntiConvulsant Syndrome Association
P.O. Box 7416
Annan, Intl DG12 5ET
United Kingdom
Tel: 01 461 206 870
Fax: 01 461 206 870
Email: facsline3@aol.com
Internet: http://www.facsline.org

Organization For Anti-Convulsant Syndrome
PO Box 772
Pilling
Preston, Intl PR3 6WW
UK
Tel: 01253 790000
Fax: 01253 790000
Email: Janet.oacs@btinternet.com
Internet: http://www.oacs-uk.co.uk/

Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Tel: (301)251-4925
Fax: (301)251-4911
Tel: (888)205-2311
TDD: (888)205-3223
Email: ordr@od.nih.gov
Internet: http://rarediseases.info.nih.gov/Default.aspx

For a Complete Report

For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc. ® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html

related physicians

related services

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.